2d3v: Difference between revisions

Revision as of 21:16, 28 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:2d3v.png

Template:STRUCTURE 2d3v

Crystal Structure of Leukocyte Ig-like Receptor A5 (LILRA5/LIR9/ILT11)Crystal Structure of Leukocyte Ig-like Receptor A5 (LILRA5/LIR9/ILT11)

Template:ABSTRACT PUBMED 16675463

About this StructureAbout this Structure

2D3V is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

Crystal structure of the human monocyte-activating receptor, "Group 2" leukocyte Ig-like receptor A5 (LILRA5/LIR9/ILT11)., Shiroishi M, Kajikawa M, Kuroki K, Ose T, Kohda D, Maenaka K, J Biol Chem. 2006 Jul 14;281(28):19536-44. Epub 2006 May 3. PMID:16675463

Page seeded by OCA on Mon Jul 28 21:15:58 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2d3v.gif|left|200px]]
+{{Seed}}
+[[Image:2d3v.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2d3v|  PDB=2d3v  |  SCENE=  }}
-'''Crystal Structure of Leukocyte Ig-like Receptor A5 (LILRA5/LIR9/ILT11)'''
+===Crystal Structure of Leukocyte Ig-like Receptor A5 (LILRA5/LIR9/ILT11)===
-==Overview==
+<!--
-Human leukocyte Ig-like receptor B1 (LILRB1) and B2 (LILRB2) belong to "Group 1" receptors and recognize a broad range of major histocompatibility complex class I molecules (MHCIs). In contrast, "Group 2" receptors show low similarity with LILRB1/B2, and their ligands remain to be identified. To date, the structural and functional characteristics of Group 2 LILRs are poorly understood. Here we report the crystal structure of the extracellular domain of LILRA5, which is an activating Group 2 LILR expressed on monocytes and neutrophils. Unexpectedly, the structure showed large changes in structural conformation and charge distribution in the region corresponding to the MHCI binding site of LILRB1/B2, which are also distinct from killer cell Ig-like receptors and Fc alpha receptors. These changes probably confer the structural hindrance for the MHCI binding, and their key amino acid substitutions are well conserved in Group 2 LILRs. Consistently, the surface plasmon resonance and flow cytometric analyses demonstrated that LILRA5 exhibited no affinities to all tested MHCIs. These results raised the possibility that LILRA5 as well as Group 2 LILRs do not play a role in any MHCI recognition but could possibly bind to non-MHCI ligand(s) on the target cells to provide a novel immune regulation mechanism.
+The line below this paragraph, {{ABSTRACT_PUBMED_16675463}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 16675463 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_16675463}}
 ==About this Structure==
@@ Line 29: / Line 33: @@
 [[Category: Shiroishi, M.]]
 [[Category: Immunoglobulin-like fold]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 23:39:25 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 21:15:58 2008''